20-3661157-G-C

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The NM_022139.4(GFRA4):ā€‹c.179C>Gā€‹(p.Pro60Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000662 in 1,360,544 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: š‘“ 0.000020 ( 0 hom., cov: 33)
Exomes š‘“: 0.0000050 ( 0 hom. )

Consequence

GFRA4
NM_022139.4 missense

Scores

2
3
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.66
Variant links:
Genes affected
GFRA4 (HGNC:13821): (GDNF family receptor alpha 4) The protein encoded by this gene is a member of the GDNF receptor family. It is a glycosylphosphatidylinositol(GPI)-linked cell surface receptor for persephin, and mediates activation of the RET tyrosine kinase receptor. This gene is a candidate gene for RET-associated diseases. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.26673228).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GFRA4NM_022139.4 linkuse as main transcriptc.179C>G p.Pro60Arg missense_variant 2/6 ENST00000290417.7 NP_071422.1 Q9GZZ7-2
GFRA4NM_145762.3 linkuse as main transcriptc.179C>G p.Pro60Arg missense_variant 2/5 NP_665705.1 Q9GZZ7-1
GFRA4XM_005260793.2 linkuse as main transcriptc.179C>G p.Pro60Arg missense_variant 2/4 XP_005260850.1 Q9GZZ7-3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GFRA4ENST00000290417.7 linkuse as main transcriptc.179C>G p.Pro60Arg missense_variant 2/61 NM_022139.4 ENSP00000290417.2 Q9GZZ7-2
GFRA4ENST00000319242.8 linkuse as main transcriptc.179C>G p.Pro60Arg missense_variant 2/51 ENSP00000313423.3 Q9GZZ7-1
GFRA4ENST00000477160.1 linkuse as main transcriptn.179C>G non_coding_transcript_exon_variant 2/41 ENSP00000435801.1 Q9GZZ7-3

Frequencies

GnomAD3 genomes
AF:
0.0000198
AC:
3
AN:
151874
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000496
AC:
6
AN:
1208670
Hom.:
0
Cov.:
37
AF XY:
0.00000679
AC XY:
4
AN XY:
588674
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000603
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000198
AC:
3
AN:
151874
Hom.:
0
Cov.:
33
AF XY:
0.0000404
AC XY:
3
AN XY:
74188
show subpopulations
Gnomad4 AFR
AF:
0.0000242
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 27, 2024The c.179C>G (p.P60R) alteration is located in exon 2 (coding exon 2) of the GFRA4 gene. This alteration results from a C to G substitution at nucleotide position 179, causing the proline (P) at amino acid position 60 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.12
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.12
.;T
Eigen
Benign
-0.13
Eigen_PC
Benign
-0.22
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.55
T;T
M_CAP
Pathogenic
0.75
D
MetaRNN
Benign
0.27
T;T
MetaSVM
Benign
-0.83
T
MutationAssessor
Uncertain
2.1
M;M
PrimateAI
Pathogenic
0.80
D
PROVEAN
Benign
-1.0
N;N
REVEL
Benign
0.12
Sift
Benign
0.047
D;T
Sift4G
Benign
0.13
T;T
Polyphen
1.0
D;B
Vest4
0.16
MutPred
0.38
Loss of glycosylation at P60 (P = 0.0328);Loss of glycosylation at P60 (P = 0.0328);
MVP
0.70
MPC
1.0
ClinPred
0.56
D
GERP RS
2.1
Varity_R
0.052
gMVP
0.57

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1215056468; hg19: chr20-3641804; API